Literature DB >> 19302043

Regulatory lymphocytes and intestinal inflammation.

Ana Izcue1, Janine L Coombes, Fiona Powrie.   

Abstract

The immune system is pivotal in mediating the interactions between host and microbiota that shape the intestinal environment. Intestinal homeostasis arises from a highly dynamic balance between host protective immunity and regulatory mechanisms. This regulation is achieved by a number of cell populations acting through a set of shared regulatory pathways. In this review, we summarize the main lymphocyte subsets controlling immune responsiveness in the gut and their mechanisms of control, which involve maintenance of intestinal barrier function and suppression of chronic inflammation. CD4(+)Foxp3(+) T cells play a nonredundant role in the maintenance of intestinal homeostasis through IL-10- and TGF-beta-dependent mechanisms. Their activity is complemented by other T and B lymphocytes. Because breakdown in immune regulatory networks in the intestine leads to chronic inflammatory diseases of the gut, such as inflammatory bowel disease and celiac disease, regulatory lymphocytes are an attractive target for therapies of intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302043     DOI: 10.1146/annurev.immunol.021908.132657

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  215 in total

Review 1.  Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells.

Authors:  Hye-Jung Kim; Harvey Cantor
Journal:  Semin Immunol       Date:  2011-12       Impact factor: 11.130

2.  CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice.

Authors:  Oscar Medina-Contreras; Duke Geem; Oskar Laur; Ifor R Williams; Sergio A Lira; Asma Nusrat; Charles A Parkos; Timothy L Denning
Journal:  J Clin Invest       Date:  2011-12       Impact factor: 14.808

Review 3.  Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers.

Authors:  Megan E Himmel; Yu Yao; Paul C Orban; Theodore S Steiner; Megan K Levings
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

Review 4.  Treg vaccination with a strong-agonistic insulin mimetope.

Authors:  Benno Weigmann; Carolin Daniel
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

Review 5.  Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

Authors:  Thomas R Malek; Iris Castro
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

6.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: induction and control of regulatory T cells in the gastrointestinal tract: consequences for local and peripheral immune responses.

Authors:  Y Belkaid; O Liesenfeld; R M Maizels
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

7.  CCR6 marks regulatory T cells as a colon-tropic, IL-10-producing phenotype.

Authors:  Kazuya Kitamura; Joshua M Farber; Brian L Kelsall
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

8.  Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells.

Authors:  Dan Blat; Ehud Zigmond; Zoya Alteber; Tova Waks; Zelig Eshhar
Journal:  Mol Ther       Date:  2014-03-06       Impact factor: 11.454

Review 9.  Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation.

Authors:  Darwin J Prockop; Joo Youn Oh
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

10.  PC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection.

Authors:  Anke R M Kraft; Myriam F Wlodarczyk; Laurie L Kenney; Liisa K Selin
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.